Investigating fascin functions beyond its effect on metabolism and correlating the levels of dysregulated metabolites with fascin expression in samples from breast cancer patients will indicate the clinical relevance of the findings reported in this study. The gene discussed is FSCN1; the disease is breast carcinoma.